Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: AIDS. 2022 Mar 1;36(3):355–362. doi: 10.1097/QAD.0000000000003119

Table 1:

Demographic and Clinical Characteristics of Participants With A Scheduled Visit in the 6.5 Months Pre- and During- the COVID-19 Pandemic, Johns Hopkins HIV Clinical Cohort

Pre-Pandemic
Sep 1, 2019 – Mar 15, 2020
(n = 2,010)
Pandemic
Mar 16, 2020 – Sep 30, 2020
(n = 1,929)
Age Category
20–39 282 (14%) 273 (14%)
40–59 992 (49%) 949 (49%)
60+ 736 (37%) 707 (37%)
Male 1,247 (63%) 1,213 (63%)
Race
White 379 (19%) 369 (19%)
Black 1,552 (77%) 1,482 (77%)
Other 79 (4%) 78 (4%)
Hispanic 52 (3%) 53 (3%)
HIV Risk Factor
Men who had Sex with Men 634 (32%) 612 (32%)
Intravenous Drug Use 477 (24%) 441 (23%)
High-risk Heterosexual Contact 1,070 (53%) 1,031 (53%)
Viral Suppression 1
Not Virally Suppressed 146 (7%) 116 (6%)
Virally Suppressed 1,713 (85%) 1,665 (86%)
No viral load in the past year 151 (8%) 148 (8%)
Duration of Care at JHHCC
< 1 year 74 (4%) 79 (4%)
1–5 years 325 (16%) 302 (16%)
6–10 years 349 (17%) 324 (17%)
10+ years 1,262 (63%) 1,224 (63%)
History of Depression 824 (41%) 775 (40%)
Recent Heroin Use 2 79 (4%) 72 (4%)
Recent Cocaine Use 2 134 (7%) 121 (6%)
Recent Hazardous Alcohol Use 2 166 (8%) 152 (8%)
Recent Smoking 2 672 (33%) 624 (32%)
1

Virally suppressed at most recent lab within the year prior to each study period

2

As recorded on medical chart review